These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2968699)

  • 1. Analysis of rejection in cyclosporine-treated cardiac allograft recipients.
    Macris MP; Frazier OH; Burstein T; McAllister HA; Van Buren CT
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):346-50. PubMed ID: 2968699
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of rejection in cyclosporine-treated cardiac allograft recipients.
    Burstain TL; Frazier OH; Schnee MJ; Kerman RH; Lorber MI; Cooley DA; Radovancevic B; Colon R; McAllister H; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2531-3. PubMed ID: 2978895
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the donor-specific immune response by cyclosporin-A following renal transplantation.
    Keown PA; Stiller CR; Ulan RA; Sinclair NR; Rankin C; Carruthers G; Wall WJ
    Transplant Proc; 1981 Sep; 13(3):1669-72. PubMed ID: 6458135
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine in cardiac transplantation.
    Devineni R; McKenzie N; Keown P; Kostuk W; Stiller C; Silver M
    Can J Surg; 1984 May; 27(3):252-4. PubMed ID: 6232993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of cyclosporine on in situ cellular and humoral immune responses during allograft rejection.
    Orosz CG; Sirinek LP; Zinn NE; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1175-7. PubMed ID: 3274303
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients.
    Macris MP; Frazier OH; Van Buren CT; Duncan JM
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261
    [No Abstract]   [Full Text] [Related]  

  • 7. The immunobiology of experimental lung transplantation with cyclosporine immunosuppression: cytolytic T lymphocytes and delayed type hypersensitivity in rejecting and tolerant recipients.
    Norin AJ
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):125-30. PubMed ID: 2966476
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological study of cyclosporine in heterotopic transplantation of canine hearts.
    Suzuki S; Mizuochi I; Amemiya H
    Transplantation; 1985 May; 39(5):565-8. PubMed ID: 3158109
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal function and blood pressure in heart transplant recipients treated with cyclosporine.
    Rottembourg J; Mattei MF; Cabrol A; Leger P; Aupetit B; Beaufils H; Gluckman JC; Pavie A; Gandjbakhch I; Cabrol C
    J Heart Transplant; 1985; 4(4):404-8. PubMed ID: 3916515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
    Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
    J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine-induced transplantation unresponsiveness in rat cardiac allograft recipients: in vitro determination of helper and suppressor activity.
    Uhteg LC; Salomon DR; Rocher LL; Kupiec-Weglinski JW; Araujo JL; Rubin MF; Tilney NL; Carpenter CB
    J Immunol; 1985 Sep; 135(3):1800-5. PubMed ID: 3160780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of cyclosporine in preventing cardiac allograft rejection. I. Rate of entry of lymphocytes from the blood, fibrin deposition, and expression of Ia antigens on infiltrating cells.
    Cox JH; Chisholm PM
    Transplantation; 1987 Mar; 43(3):338-42. PubMed ID: 3547786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the immunologic and pharmacodynamic effects of cyclosporine following renal transplantation.
    Keown PA; Coles R; Flechner I; Stawecki M; Stiller CR
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):252-6. PubMed ID: 2947367
    [No Abstract]   [Full Text] [Related]  

  • 14. Is cyclosporine's nephrotoxicity related to its immunosuppressive effectiveness?
    Hakim M; White DJ; Cory-Pearce R; English TA; Wallwork J
    J Heart Transplant; 1985 Feb; 4(2):217-9. PubMed ID: 3916489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine inhibits nonspecific transfusion-induced immunity in dogs.
    Kyriakides GK; Esquenazi V; Olson L; Milgrom M; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1432-3. PubMed ID: 2978877
    [No Abstract]   [Full Text] [Related]  

  • 16. Conversion from cyclosporine to azathioprine in heart transplant recipients.
    Stevens L; Halbrook H; Berron K; Spears C; Hormuth D
    J Heart Transplant; 1988; 7(2):119-22. PubMed ID: 3284982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune status of transplant recipients immunosuppressed with cyclosporin-A.
    White DJ; Plumb A; Calne RY
    Transplant Proc; 1981 Sep; 13(3):1666-8. PubMed ID: 6458134
    [No Abstract]   [Full Text] [Related]  

  • 18. The lymphocyte subpopulations in cyclosporine-treated human heart rejection.
    Weintraub D; Masek M; Billingham ME
    J Heart Transplant; 1985 Feb; 4(2):213-6. PubMed ID: 3916488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prophylactic rabbit antithymocyte globulin in cardiac allograft recipients treated with cyclosporine.
    Kawaguchi A; Szentpetery S; Mohanakumar T; Barnhart GR; Lower RR
    J Heart Transplant; 1987; 6(4):214-7. PubMed ID: 3312532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.